Program Offering and Eligibility
The HEMLIBRA Co-pay Program may help eligible commercially insured patients who have been prescribed HEMLIBRA with their medicine co-pays.
Program offering
Eligible commercially insured patients can save up to $15,000 per calendar year in their HEMLIBRA medicine costs. They pay as little as $0 per co-pay.
Patients may owe more than $0 depending on how the health insurance plan applies manufacturer co-pay assistance to out-of-pocket costs.
Eligibility
- Have been prescribed HEMLIBRA for an FDA-approved indication
- Are 18 years of age or older, or have a caregiver or have a legally authorized person to manage the patient's co-pay assistance
- Have commercial (private or non-governmental) insurance.* This includes plans available through state and federal health insurance exchanges
- Reside and receive treatment in the United States or U.S. Territories
- Are not receiving assistance through the Genentech Patient Foundation or any other charitable organization for the same expenses covered by the program
- Are not a government beneficiary and/or participant in a federal or state-funded health insurance program (e.g., Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD, TRICARE)
*Commercial insurance includes plans you receive from your job or plans from the Health Insurance Marketplace. Government programs like Medicare and Medicaid are not commercial insurance.
If a patient is not eligible for the HEMLIBRA Co-pay Program, there may be other options for co-pay assistance. Call (866) 436-5427 or visit HEMLIBRA.com/access to learn more.
Call 
to change word size.